About Us

Choosing the right treatment for hepatitis C virus infection can be difficult. Patients and doctors want to conquer the infection and prevent liver damage without introducing other problems. In the past decade, drug development has occurred so rapidly that patients and clinicians must base their decisions on incomplete information. There have been no randomized clinical trials comparing one drug to another to provide information on the differences in cure rates and long-term effects.

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails

Image

Hand pointing to email icon